North America Plant-based Vaccines Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Plant-based Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Plant-based Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Plant-based Vaccines Market Regional Analysis

6.2 North America Plant-based Vaccines Market Revenue 2019-2028 (US$ Million)

6.3 North America Plant-based Vaccines Market Forecast Analysis

7. North America Plant-based Vaccines Market Analysis – by Vaccine Type

7.1 Bacterial Vaccines

7.1.1 Overview
7.1.2 Bacterial Vaccines: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Viral Vaccines

7.2.1 Overview
7.2.2 Viral Vaccines: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Parasite Vaccines

7.3.1 Overview
7.3.2 Parasite Vaccines: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Plant-based Vaccines Market Analysis – by Source

8.1 Tobacco Plant

8.1.1 Overview
8.1.2 Tobacco Plant: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Maize

8.2.1 Overview
8.2.2 Maize: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Potato

8.3.1 Overview
8.3.2 Potato: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Plant-based Vaccines Market Analysis – by Application

9.1 Influenza

9.1.1 Overview
9.1.2 Influenza: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Zika Virus

9.2.1 Overview
9.2.2 Zika Virus: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Ebola Virus

9.3.1 Overview
9.3.2 Ebola Virus: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Poultry Disease

9.4.1 Overview
9.4.2 Poultry Disease: North America Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Plant-based Vaccines Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Plant-based Vaccines Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Plant-based Vaccines Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Plant-based Vaccines Market Breakdown, by Vaccine Type
10.2.1.1.2 US: North America Plant-based Vaccines Market Breakdown, by Source
10.2.1.1.3 US: North America Plant-based Vaccines Market Breakdown, by Application

10.2.1.2 Canada: North America Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Plant-based Vaccines Market Breakdown, by Vaccine Type
10.2.1.2.2 Canada: North America Plant-based Vaccines Market Breakdown, by Source
10.2.1.2.3 Canada: North America Plant-based Vaccines Market Breakdown, by Application

10.2.1.3 Mexico : North America Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Plant-based Vaccines Market Breakdown, by Vaccine Type
10.2.1.3.2 Mexico : North America Plant-based Vaccines Market Breakdown, by Source
10.2.1.3.3 Mexico : North America Plant-based Vaccines Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 British American Tobacco p.l.c.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Creative Biolabs, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Fraunhofer

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 iBio, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Leaf Expression Systems Ltd.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 LenioBio

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Lumen Bioscience, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Medicago, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 ZYUS Life Sciences Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Plant-based Vaccines Market

Analysis By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, and Others), Source (Tobacco Plant, Maize, Potato, and Others), and Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, and Others)